 An important preliminary point is that almost all serious advocates of allowing payment for human organs argue not for an unfettered ‘free market’ but for a regulated one.  Radcliffe Richards et al. (1998, 1950) for example, in their paper “The Case for Allowing Kidney Sales” say: 